Follica, the Biotech With Potential Drug Against Baldness, Nabs $7.5M Venture Financing

Published: Jun 02, 2010

Xconomy -- Follica has raised more money for its quest against hair follicle disorders like male pattern baldness. The biotech startup, which is developing drugs that could spur the formation of new hair follicles, has raised $7.5 million in equity financing, according to an SEC filing.

Back to news